CClinicalTrials.gg
CompletedNCT05015933Updated Aug 24, 2021

Intrathecal Pump Refills at Home

An interventional study of Pump refill procedure at home in Intrathecal Drug Delivery, Implantable Pump and Telemedicine, sponsored by Moens Maarten. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-24.

Sponsored by Moens Maarten · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this pilot study is to evaluate the feasibility, safety and effectiveness of intrathecal pump refill procedures at home. It is our hypothesis that a refill at home will be safe, effectiveness and feasible, as is demonstrated in The Netherlands, and preferred by patients.

02

Conditions studied

  • Intrathecal Drug Delivery
  • Implantable Pump
  • Telemedicine
03

In context

Lead sponsor

Moens Maarten is the lead sponsor of 22 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient receives intrathecal drug therapy
  • Patient is at least 18 years old
  • Native French-or Dutch speaking persons.

Exclusion criteria

Exclusion Criteria:

  • Patients \< 18 years old.
  • No native Dutch or French speaking persons.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Refill at home

    Patients will have one pump refill at home instead of at the hospital.

    Procedure: Pump refill procedure at home

Interventions

  • ProcedurePump refill procedure at home

    Implantable pump refill is performed at home

06

What researchers measure

Primary outcomes

  1. Patient satisfaction

    A seven-point Likert scale asking the patient to rate the overall level of satisfaction with the refill at home will be used.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  2. Successful pump refill

    A binary variable to indicate success or failure of this intervention, reported by the physician.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  3. Patient safety

    A seven-point Likert scale asking the patient to rate the overall level of safety with the refill at home will be used.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  4. Physician safety

    A seven-point Likert scale asking the physician to rate the overall level of safety with the refill at home will be used.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

Secondary outcomes

  1. Environmental safety

    An open question in which the physician can indicate whether there were any situations that were not safe.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  2. Clean, sterile procedure

    An open question in which the physician can mention all potential risks.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  3. An objective confirmation of correct injection in the pump by ultrasound.

    After the refill procedure is performed, an ultrasound will be made to visually ensure that the refill was correctly performed without loss of liquor outside the pump.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  4. Adverse events

    All adverse events will systematically be reported by the physician.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  5. Patient feasibility

    A seven-point Likert scale asking the patient to rate the overall level of feasibility with the refill at home will be used.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  6. Quality of teleconsultant connection by teleconsultant

    Quality of the internet connection will be evaluated by the teleconsultant.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  7. Time burden for teleconsultant

    The time will be measured from the beginning until the end of the call.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  8. Physician feasibility

    A seven-point Likert scale asking the physician to rate the overall level of feasibility with the refill at home will be used.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  9. Quality of teleconsultant connection by physician

    Quality of the internet connection will be evaluated by the physician.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  10. Time burden for physician

    The time will be measured from the beginning until the end of the call.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

  11. Patient preference

    Patients will be asked to indicate whether they prefer to have their next refill at home.

    Time frame: Once, at the moment of the study visit, immediately after the pump refill

07

Study locations

1 site
  • Universitair Ziekenhuis Brussel
    Jette, 1090, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05015933
Lead sponsor
Moens Maarten
Responsible party
Moens Maarten (principal investigator, Universitair Ziekenhuis Brussel) — Sponsor-investigator
First posted
Aug 23, 2021
Start date
Aug 9, 2021
Primary completion
Aug 11, 2021
Completion
Aug 11, 2021
Last update
Aug 24, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion